Eric Joseph
Stock Analyst at JP Morgan
(1.30)
# 3,323
Out of 4,829 analysts
135
Total ratings
34.88%
Success rate
-13.61%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Maintains: Overweight | $45 → $44 | $6.99 | +529.47% | 3 | May 9, 2025 | |
| NVAX Novavax | Maintains: Underweight | $9 → $7 | $5.98 | +17.15% | 8 | May 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Overweight | $75 → $67 | $44.23 | +51.48% | 10 | May 7, 2025 | |
| OPK OPKO Health | Initiates: Neutral | n/a | $1.24 | - | 4 | Apr 25, 2025 | |
| BLUE bluebird bio | Upgrades: Neutral | n/a | $3.50 | - | 3 | Feb 24, 2025 | |
| PLRX Pliant Therapeutics | Downgrades: Neutral | n/a | $1.41 | - | 4 | Feb 10, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Overweight | $31 → $30 | $9.50 | +215.79% | 7 | Jan 29, 2025 | |
| IGMS IGM Biosciences | Upgrades: Neutral | n/a | $1.13 | - | 8 | Jan 13, 2025 | |
| VIR Vir Biotechnology | Maintains: Neutral | $10 → $14 | $5.09 | +175.32% | 5 | Jan 9, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $40.42 | +75.66% | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $43 | $33.64 | +27.82% | 4 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $38 | $6.69 | +468.01% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $2.13 | +979.81% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $6.59 | +158.16% | 2 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $3.00 | +600.00% | 5 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $17.41 | +175.70% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $5.27 | +89.75% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.90 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $1.30 | +1,053.85% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $1.63 | +820.25% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $30.07 | +56.30% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $1.47 | +308.16% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $4.33 | +130.95% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $4.09 | +168.95% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $39.85 | +2.89% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.40 | +1,150.00% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $0.54 | +831.10% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.72 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $3.04 | +261.84% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.35 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $120 | $6.02 | +1,895.01% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $4.48 | +6,596.43% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.18 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $4.23 | +1,082.03% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $1.32 | +581.82% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.55 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $1.64 | +2,460.98% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $0.71 | +1,733.05% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $0.70 | +1,470.98% | 3 | Nov 14, 2018 |
Rocket Pharmaceuticals
May 9, 2025
Maintains: Overweight
Price Target: $45 → $44
Current: $6.99
Upside: +529.47%
Novavax
May 9, 2025
Maintains: Underweight
Price Target: $9 → $7
Current: $5.98
Upside: +17.15%
PTC Therapeutics
May 7, 2025
Maintains: Overweight
Price Target: $75 → $67
Current: $44.23
Upside: +51.48%
OPKO Health
Apr 25, 2025
Initiates: Neutral
Price Target: n/a
Current: $1.24
Upside: -
bluebird bio
Feb 24, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.50
Upside: -
Pliant Therapeutics
Feb 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.41
Upside: -
Nurix Therapeutics
Jan 29, 2025
Maintains: Overweight
Price Target: $31 → $30
Current: $9.50
Upside: +215.79%
IGM Biosciences
Jan 13, 2025
Upgrades: Neutral
Price Target: n/a
Current: $1.13
Upside: -
Vir Biotechnology
Jan 9, 2025
Maintains: Neutral
Price Target: $10 → $14
Current: $5.09
Upside: +175.32%
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $40.42
Upside: +75.66%
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $33.64
Upside: +27.82%
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $6.69
Upside: +468.01%
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $2.13
Upside: +979.81%
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $6.59
Upside: +158.16%
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $3.00
Upside: +600.00%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $17.41
Upside: +175.70%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $5.27
Upside: +89.75%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.90
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $1.30
Upside: +1,053.85%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $1.63
Upside: +820.25%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $30.07
Upside: +56.30%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $1.47
Upside: +308.16%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $4.33
Upside: +130.95%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $4.09
Upside: +168.95%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $39.85
Upside: +2.89%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.40
Upside: +1,150.00%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $0.54
Upside: +831.10%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $2.72
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $3.04
Upside: +261.84%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $8.35
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $120
Current: $6.02
Upside: +1,895.01%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $4.48
Upside: +6,596.43%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $6.18
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $4.23
Upside: +1,082.03%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $1.32
Upside: +581.82%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $2.55
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $1.64
Upside: +2,460.98%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $0.71
Upside: +1,733.05%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $0.70
Upside: +1,470.98%